03 January 2019 10:15 CET

Karo Intressenter AB publishes supplement to offer document regarding its public cash offer to the shareholders in Karo Pharma Aktiebolag

#EQT VIII #Karo Pharma

Fore more information, click here.

Latest news

25 September 2023
EQT Private Equity to sell LimaCorporate, one of the global leaders in joint replacement solutions
24 August 2023
BPEA EQT exits Coforge, a multinational Digital IT Solutions & Technology Consulting Services provider
23 August 2023
EQT Growth leads USD 85 million investment round into global corporate wellness platform Gympass
21 August 2023
Repurchases of shares by EQT AB during week 33, 2023. The current share buyback program has been finalised
17 August 2023
EQT Private Equity to take SUSE private and work towards full potential in private setting, with shareholders given option to remain invested or sell at attractive cash offer